BALAXI.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana...

Stats
本日の出来高	3 454.00
平均出来高	19 609.00
時価総額	6.51B
EPS	INR14.06 ( 2023-09-30 )
Last Dividend	INR0.500 ( 2022-07-01 )
Next Dividend	INR0 ( N/A )
P/E	-115.94
ATR14	INR2.00 (0.34%)

ボリューム相関

長: 0.00 (neutral)

短: 0.66 (moderate)

Signal:(52.776) Neutral

Balaxi Pharmaceuticals 相関

10 最も正の相関
LAKSHVILAS.NS	0.837
ASIANPAINT.NS	0.829
KIRIINDUS.NS	0.822
BGLOBAL.NS	0.819
DIXON.NS	0.802
DMART.NS	0.801

10 最も負の相関
DFMFOODS.NS	-0.833
TOUCHWOOD.NS	-0.827

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Balaxi Pharmaceuticals 相関 - 通貨/商品

0.29
( neutral )

0.24
( neutral )

-0.02
( neutral )

0.13
( neutral )

0.59
( weak )

-0.07
( neutral )

Balaxi Pharmaceuticals 財務諸表

Annual	2022
収益:	INR3.36B
総利益:	INR1.34B (39.83 %)
EPS:	INR45.81

FY	2022
収益:	INR3.36B
総利益:	INR1.34B (39.83 %)
EPS:	INR45.81

FY	2022
収益:	INR2.79B
総利益:	INR837.92M (29.99 %)
EPS:	INR47.66

FY	2021
収益:	INR2.31B
総利益:	INR591.85M (25.58 %)
EPS:	INR38.14

Financial Reports:

No articles found.

Balaxi Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Balaxi Pharmaceuticals Dividend Information - No Dividend Player

Dividend Sustainability Score: 2.50 - low (50.00%) | Divividend Growth Potential Score: 0.0536 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.500	2022-07-01
Last Dividend	INR0.500	2022-07-01
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR0.500	--
Avg. Dividend % Per Year	0.02%	--
Score	0.4	--
Div. Sustainability Score	2.50
Div.Growth Potential Score	0.0536
Div. Directional Score	1.279	--

Next Divdend (Est)
(2024-05-08)

INR0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

0.40

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2022	INR0.500	0.10%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SOUTHBANK.NS	Dividend Junior	2023-08-17	Sporadic	25	0.42%
MONARCH.NS	Dividend Junior	2023-09-14	Annually	3	0.20%
HERANBA.NS	Dividend Junior	2023-08-17	Annually	4	0.20%
BHEL.NS	Dividend Junior	2023-08-11	Annually	21	0.26%
RAMCOIND.NS	Dividend Junior	2023-08-02	Annually	23	0.32%
KOKUYOCMLN.NS	Dividend Junior	2023-07-20	Sporadic	16	0.16%
EQUITASBNK.NS	Dividend Junior	2023-07-27	Insufficient data to determine frequency	2	0.56%
ALKEM.NS	Dividend Junior	2023-08-09	Semi-Annually	9	0.71%
SWARAJENG.NS	Dividend Knight	2023-07-06	Annually	23	2.81%
NELCO.NS	Dividend Junior	2023-06-06	Sporadic	22	0.24%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0199	1.500	-0.398	-0.597	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.0309	1.500	-1.454	-2.18	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	31.60	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.82	2.00	8.73	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.82	2.00	8.09	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.424	1.000	6.26	6.26	[0.2 - 0.8]
operatingProfitMarginTTM	0.161	1.000	8.77	8.77	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.50

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-116.75	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.0309	2.50	-0.935	-2.18	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.82	2.00	8.73	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.82	2.00	8.73	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0149	1.000	-2.13	0	[0.1 - 0.5]
Total Score				0.0536

Balaxi Pharmaceuticals

Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana. The Company’s products include pharmaceuticals products, food products and builders’ hardware products. The company operates through the operating segment international wholesale trading. Its pharmaceutical formulations and builders’ hardware products are contract manufactured from manufacturing plants in India. The firm offers a range of food and biscuit products under the brand name YAP. Its subsidiaries include Balaxi Global DMCC.